Friday - June 6, 2025
FTC Issues Warning Letter to Novartis Pharmaceuticals
May 22, 2025
WASHINGTON, May 22 -- The Federal Trade Commission Bureau of Competition issued the following warning letter on May 21, 2025:

* * *

To: Elizabeth McGee

General Counsel

Novartis Pharmaceuticals Corp.

1 Health Plaza, East Hanover, New Jersey 07936

Elizabeth.mcgee@novartis.com

Re: Improper Orange Book Patent Listings for Seebri and Utibron

Dear Ms. McGee,

I write regarding Novart . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products